Close | |
![]() |
|
Figure 4: Survival graphs of the study subjects with respect to grade o tumor where better sur-vival is seen in well differentiated tumor as compared to poorly differentiated and significantly better survival in GBC with complete membranous immuno-expression of Beta-Catenin as com-pared to incomplete membranous and negative immuno-expression of Beta-Catenin. (p=0.004) |
|